SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model
Respirology, 05/18/2012
Van TT et al. – The findings suggest that SU6668 has a promising therapeutic effect on the progression of Malignant pleural mesothelioma in vivo through its anti–angiogenic effects.



